Characteristics and outcome of systemic treatment for metastatic or unresectable thymic carcinoma: A single institution experience.
I-Wei HoYu-Ling PanJiun-I LaiChun-Yu LiuPublished in: Thoracic cancer (2023)
We highlight the critical role of platinum-based chemotherapy agents as a primary treatment modality in advanced thymic carcinoma, underscoring the efficacy of platinum as a first-line option for recurrent disease, even in cases previously treated with platinum. Additionally, our findings indicate that CD5 positivity could be associated with improved PFS, suggesting its potential as a prognostic marker.